Nihon Kohden - NTX ZM-540/541P
by Nihon Kohden

Follow Us
DESCRIPTION
ECG, Respiration, NIBP, SpO2

Allows for monitoring of up to eight vectors of ECG, respiration, continuous SpO2 and NIBP at the Central Monitor. NTX is designed to provide hospitals with more flexible monitoring on higher-acuity patients. Ergonomically designed to provide patient comfort and mobility, it bridges the gap between a traditional bedside monitor and an ambulatory transmitter.                     The NTX allows hospitals to safely monitor higher-acuity patients while maintaining the flexibility, comfort and mobility associated with the ambulatory patient. Integrated 2.2" color screen displays continuous real-time waveform and vital signs, and provides data review with 10 minutes of full disclosure waveforms and 10 minutes of vital signs data. The display also indicates lead status, battery status and pulse strength. The NTX transmitter operates in the protected WMTS frequency band and provides economical operation through the use of three alkaline "AA" batteries.

FORUMSView All
Ask a New Question
DOCUMENTS / MANUALSView All
SERVICE COMPANIESView All Telemetry-Central Station Companies

FEATURES

[*] Full five-year parts and labor warranty          [*] Transmitters operate for up to three days using two or three “AA” alkaline batteries          [*] Low-battery warning sound and indicator lamp on each transmitter          [*] Call button can activate recorder and nurse call at central monitor (ZM-520/521PA and ZM-530/530PA only)          [*] Can use either a three-electrode (for single-vector ECG monitoring) or six-electrode (for eight-vector ECG monitoring) patient cable          [*] All transmitters monitor ECG and impedance respiration          [*] Lead-off indicators on each transmitter indicate which lead requires attention          [*] Automatic data integration to your electronic charting system using the CGS-9002 HL7 Gateway System

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree